Buy NDC00517-4605-25 Part of Luitpold Pharmaceuticals Inc with NSN 6505-01-499-7214
MPN: NDC00517-4605-25
Alternate P/N: NDC00517460525
Manufacturer: Luitpold Pharmaceuticals Inc
NSN: 6505-01-499-7214
Item Name: Glycopyrrolate Inje
CAGE Code: 32288
Part number NDC00517-4605-25 is available for immediate shipping. The NSN for part number is 6505014997214. This part is manufactured by Luitpold Pharmaceuticals Inc. It is described as Glycopyrrolate Inje. Would you like to request a quote for part number NDC00517-4605-25? Please fill out the form.
The form includes various important fields such as your contact details, Need Parts By, and Quantity. Please make sure to fill out all these fields accordingly before clicking to submit the form. Our experts will review your answers for Need Parts By and Quantity to calculate your quote.
Upload RFQ Sheet
If you have more than one item, upload your spreadsheet here
NSN Information for Part Number NDC00517-4605-25 with NSN 6505-01-499-7214, 6505014997214
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-499-7214 Item Description: Glycopyrrolate Inje | 6505 | 014997214 | M | P | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| U | A | |||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| Ndc00517-4605-25 | 2 | 2 | 3 |
Characteristics Data of NSN 6505-01-499-7214, 6505014997214
| MRC | Criteria | Characteristic |
|---|---|---|
| AJUC | AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER | 120808 |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 0.200 MILLIGRAMS GLYCOPYRROLATE PER MILLILITER |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 5.000 MILLILITERS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 25 |
| CSGS | ADMINISTRATION | INTRAMUSCULAR |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | GLYCOPYRROLATE INJECTION USP 5ML VIAL 25S |
| FEAT | SPECIAL FEATURES | 5ML MULTIPLE DOSE VIALS FOR USE AS A PREOPERATIVE ANTIMUSCARINIC TO REDUCE SALIVARY, TRACHEOBRONCHIAL, AND PHARYNGEAL SECRETIONS; TO REDUCE THE VOLUME AND FREE ACIDITY OF GASTRIC SECRETIONS; AND, TO BLOCK CARDIAC VAGAL INHIBITORY REFLEXES D |
Sought-After NSN Components List
Leading NSN Part Manufacturers
